PCM
ONC

Prelude Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Prelude Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,400
Closed -$1.18M – 2036
2021
Q1 		$1.18M Buy
3,400
+2,200
+183% +$728K 0.03% 539
2020
Q4 		$310K Buy
+1,200
New +$330K 0.01% 905

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Prelude Capital Management's ONC Position: Q3 2024 in Review

Prelude Capital Management sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 4,300 shares — an estimated $613K sold.

Prelude Capital Management first reported a position in ONC in Q2 2018 and held it in 5 quarters. The position peaked at $1.09M in Q1 2024. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • Prelude Capital Management reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • Prelude Capital Management sold 4,300 BeOne Medicines Ltd shares in Q3 2024, an estimated $613K.
  • Prelude Capital Management first reported a position in BeOne Medicines Ltd in Q2 2018 and held it in 5 quarters.
  • Prelude Capital Management's BeOne Medicines Ltd position peaked at $1.09M in Q1 2024.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on Prelude Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.